‌

US Patent 11286293 Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

Patent 11286293 was granted and assigned to Zymeworks Inc. on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 11286293 Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo